The cost-utility of early use of high-flow nasal cannula in bronchiolitis

ABSTRACT: Background: High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings. This study aimed to evaluate the cost-effectiveness of e...

Full description

Autores:
Buendía Rodríguez, Jefferson Antonio
Acuña Cordero, Ranniery
Rodríguez Martínez, Carlos Enrique
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/44934
Acceso en línea:
https://hdl.handle.net/10495/44934
Palabra clave:
Economía y Organizaciones para la Atención de la Salud
Health Care Economics and Organizations
Salud Pública
Public Health
Atención a la Salud
Delivery of Health Care
Asma
Asthma
Análisis Costo-Beneficio
Cost-Benefit Analysis
Cánula
Cannula
Oxígeno
Oxygen
https://id.nlm.nih.gov/mesh/D004472
https://id.nlm.nih.gov/mesh/D011634
https://id.nlm.nih.gov/mesh/D003695
https://id.nlm.nih.gov/mesh/D001249
https://id.nlm.nih.gov/mesh/D003362
https://id.nlm.nih.gov/mesh/D000072601
https://id.nlm.nih.gov/mesh/D010100
Rights
openAccess
License
https://creativecommons.org/licenses/by/4.0/
Description
Summary:ABSTRACT: Background: High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings. This study aimed to evaluate the cost-effectiveness of early use of HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. Methods: A decision tree model was used to estimate the cost-effectiveness of HFNC compared with oxygen by nasal cannula (control strategy) in an infant with bronchiolitis in the emergency setting. Cost data were obtained from a retrospective study on bronchiolitis from tertiary centers in Rionegro, Colombia, while utilities were collected from the literature. Results: The QALYs per patient calculated in the base-case model were 0.9141 (95% CI 0.913–0.915) in the HFNC and 0.9105 (95% CI 0.910–0.911) in control group. The cost per patient was US$368 (95% CI US$ 323–411) in HFNC and US$441 (95% CI US$ 384–498) per patient in the control group. Conclusions: HFNC was cost-effective HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. The use of this technology in emergency settings will allow a more efficient use of resources, especially in low-resource countries with high prevalence of bronchiolitis .